Terms of Use

Welcome to the Noven Pharmaceuticals, Inc. website. Your access to and use of the contents of this website is subject to these Terms and Conditions of Use (“Terms of Use”) so please carefully read the following Terms of Use before viewing or using any portion of this website. Noven reserves the right, in its sole discretion, to change the Terms of Use at any time.

Use of Website. The contents of this website are intended for general information and educational purposes, not as an alternative or supplement to healthcare. By accessing and using this website, you acknowledge that you have read, understood and agreed to all the Terms of Use and will be bound by them without limitation or qualification. If you do not agree to the Terms of Use, you may not access or otherwise use this website.

Medical Information. This website contains general information relating to various medical conditions and their treatment. Such information is not meant to be a substitute for advice provided by a doctor or other qualified health care professional. Nothing on this website should be considered medical advice. You should always consult with a doctor or other health care professional about any medical questions you may have.

Content. While reasonable efforts have been made to provide accurate and current information on this website, Noven Pharmaceuticals, Inc. makes no warranties or representations as to its accuracy or completeness. You agree that all access and use of this website and its content is at your own risk. Nothing contained on this website shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of Noven, its subsidiaries, affiliates, licensors or joint venture partners, or any third party.

Product Information. The product information provided on this website is intended only for residents of the United States and its territories who generally are 18 years of age or older. Information on Attention Deficit and Hyperactivity disorder and childhood epilepsy, for example, may be appropriate to help adolescents 13 years of age or older discuss these topics with their parent(s), caregiver(s), or healthcare professional(s). The products discussed on this website may not be available in all countries or may be available under different names, in different strengths or formulations. Noven products should only be used or administered consistent with approved labeling and pursuant to your health care professional’s direction.


Limitation of Liability. In no event and under no circumstances shall Noven Pharmaceuticals, Inc., its affiliates, and subsidiaries, and their respective officers, directors, employees, agents, representatives, information providers and licensors, and their respective heirs and assigns be liable for any direct, indirect, incidental, consequential, special exemplary, punitive or other damages, even if informed of the possibility of such damages, resulting from your access to, or inability to access, this website or from your reliance on any information on this website. Noven Pharmaceuticals, Inc. shall not be liable for any damages or injury resulting from your access to, or inability to access, this website or from your reliance on any information on this site. This limitation includes damages to or for any viruses that infect your computer equipment.

Trademarks. The trademarks, product names, logos and service marks (collectively the "Trademarks") displayed on this website, whether or not appearing in large print or with a trademark symbol, are registered and unregistered Trademarks of Noven Pharmaceuticals, Inc., its subsidiaries, affiliates, licensors or joint venture partners, unless otherwise noted. The use or misuse of the Trademarks or any other content of this website, except as expressly permitted herein, is strictly prohibited and may be in violation of copyright and/or trademark laws, or other tort or property laws including libel, slander, privacy, publicity, and communications regulations and statutes.

Copyrights. Copyright © 1999-2013 Noven Pharmaceuticals, Inc. You should assume that the contents of this website are copyrighted, unless otherwise noted, and may not be copied other than for your own personal, noncommercial use, provided any copy retains all copyright or other proprietary notices and disclaimers. Without the express written consent of Noven, any further copying, distribution or publication of such personal, noncommercial copy, and any other copying, displaying, distributing, reproducing, republishing or transmission of any of the website contents, in whole or in part, in any electronic or tangible medium, and the creation of any derivative work based on the website contents, is prohibited.

Prohibited Transmissions. You agree that you will not upload, post, transmit, distribute or otherwise publish through this website any material that (1) restricts or limits the ability of any other visitor to use this website, (2) is unlawful, threatening, abusive, libelous, defamatory, obscene, pornographic, profane, or indecent, (3) constitutes or encourages conduct that would be a criminal offense, gives rise to civil liability, or otherwise violates the law, (4) violates, plagiarizes, or infringes the rights of any third party, or (5) contains a virus or other harmful or potentially harmful component.

Indemnification. You agree to indemnify, defend, and hold harmless Noven Pharmaceuticals, Inc., its affiliates, and subsidiaries, and their respective officers, directors, employees, agents, representatives, information providers and licensors, and their respective heirs and assigns from and against any and all losses, expenses, damages, and costs, including attorneys’ fees, resulting from any violation by you of the Terms of Use.

Submissions. Subject to any applicable terms and conditions set forth in our Privacy Policy, any communication or information received by Noven through any feedback or contact mechanism on this website from visitors to this website, including questions, comments, data, ideas and/or know-how, shall be deemed to be nonconfidential. Noven shall be free to use any concept, know-how, process, or technique contained in any such communication for any purpose whatsoever, without compensation or further obligation to the sender.

Links To/From Third Party Websites. This website may provide links to other websites that are maintained by third parties over whom Noven has no control. Noven is not responsible for the accuracy or any other aspect of the information contained on such sites and shall not be liable for any damages or injury arising from users’ access to such sites. Links to other sites are provided only as a convenience to users of our site. Noven Pharmaceuticals, Inc. makes no representations or warranties of any kind as to the accuracy, completeness, or currency of any information provided on such sites. If you link to any third party website from this website, you should review its terms of use and privacy policy as it may be different from those governing this website. You may not link to this website without the express prior written consent of Noven. Noven reserves the right in its sole discretion to refuse any request to link to this website.

Governing Law. These Terms of Use, your performance under it, and any disputes arising under it shall be governed exclusively by the laws of the United States of America and the State of New York, without giving effect to their conflict of laws principles. You expressly consent to the exclusive forum, jurisdiction, and venue of the courts of the state of New York in any and all actions, disputes, or controversies relating to these Terms of Use.

Use of the DAYTRANA® (methylphenidate transdermal system) Patch

The Daytrana patch contains a prescription central nervous system (brain) stimulant medicine used to treat ADHD in children and adolescents 6 to 17 years old. Use of the Daytrana patch may help increase attention and decrease impulsive and hyperactive behavior. The Daytrana patch should be used as a part of a total treatment program for ADHD that may include counseling or other therapies.

Important Safety Information

Daytrana is a controlled substance (CII) because it can be abused or lead to dependence. Keep Daytrana in a safe place to protect it from theft. Selling or giving away Daytrana may harm others and is against the law. Tell the prescribing doctor if your child has ever abused or been dependent on alcohol, prescription medicines or street drugs.

The Daytrana patch should not be used if your child has been diagnosed as very anxious, tense, or agitated; has an eye problem called glaucoma; has tics (repeated movements or sounds that cannot be controlled); has a diagnosis or family history of Tourette's syndrome; is taking a monoamine oxidase inhibitor (MAOI) medicine or has discontinued an MAOI medicine in the last 2 weeks; or is allergic to methylphenidate, acrylic adhesive, or silicone adhesive.

Serious heart problems have been reported with the Daytrana patch or other stimulant medicines including:

Tell the doctor if your child or a family member has any heart problems, heart defects, or increased blood pressure and heart rate. Remove the Daytrana patch and call the doctor right away if your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while using Daytrana. Before you start using Daytrana, tell your doctor if you have circulation problems in fingers or toes. Tell your doctor if you have or your child has numbness, pain, skin color change, or sensitivity to temperature in your fingers or toes. Call your doctor right away if you have or your child has any signs of unexplained wounds appearing on fingers or toes while using Daytrana.

Serious mental (psychiatric) problems have been reported with the Daytrana patch or other stimulant medicines including:

Tell the doctor about any mental problems your child or family members have experienced including suicide or depression, bipolar illness, mania, or psychosis. Call the doctor right away if your child has any new or worsening mental symptoms or problems while using the Daytrana patch. Tell your doctor if you, your child, or a family member has a history of vitiligo.

Be sure to tell the doctor if your child is pregnant or breast feeding.

Serious side effects such as seizures (this usually happens in children with a history of seizures), painful and prolonged erections (priapism), slowing of growth (weight and height), persistent loss of skin color (chemical leukoderma) and eyesight changes or blurred vision have been reported with the Daytrana patch. Because of the potential for lasting damage, seek medical help immediately if you or your child develops priapism. Your child should have their height, weight, and blood work checked while using the Daytrana patch and the doctor may stop treatment if a problem is found during these check-ups. Allergic skin rash may occur. Stop using the Daytrana patch and see the doctor right away if swelling, bumps, or blisters happen at or around the site where the patch is applied. If the patch is worn longer than 9 hours in a day, or if more than 1 patch is worn at a time, too much medicine has been applied. Avoid exposing the Daytrana patch to direct external heat sources such as hair dryers, heating pads, electric blankets, heated water beds, or other heat sources while wearing the patch. Heating the patch could cause too much medicine to pass into your child's body and cause serious side effects.

The most common side effects seen while using the Daytrana patch include skin problems (redness, small bumps, itching) where the patch is applied, poor appetite, nausea, vomiting, stomach pain, weight loss, tics, trouble sleeping, mood swings, and dizziness.

Please read Medication Guide and Full Prescribing Information including the Boxed Warning regarding abuse and dependence.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.